Latin America Lyme Disease Diagnostic Market

Latin America Lyme Disease Diagnostic Market Size

The size of the Latin America Lyme disease diagnostic market was valued at USD 0.99 billion in 2025. This market is expected to grow at a CAGR of 9.13% from 2026 to 2034 and be worth USD 2.17 billion by 2034, up from USD 1.08 billion in 2026.

MARKET DRIVERS

Rising Tick-Borne Infections and R&D for Early Lyme Disease Diagnosis

The growing incidence of tick-borne diseases is expected to boost the Lyme disease diagnostic market growth during the review period in this region. Additionally, factors such as increasing government initiatives in improving the healthcare facilities and the rising focus of the key market players for the R&D to introduce new tests for the diagnosis of Lyme Diseases are further expected to drive the market. Additionally, the rising patient count suffering from Lyme Diseases due to the bacteria such as Borrelia and the usage of antibiotics in treating Lyme disease at an early stage is considered positive signs to the market's growth rate. The increasing need for enhanced clinical measures attributed to the diagnostic tests' blunders in recognizing Lyme disease' early cases is estimated to favor the market during the forecast period. Availability of funds and investments by the key players to escalate the production potentiality, in turn, use for the improvements for Lyme diseases' diagnostics will act as a favor to the market growth.

MARKET RESTRAINTS

Low Diagnostic Accuracy and Poor Awareness Hamper Market Expansion

The accuracy concerns of the disease diagnosis are significantly hampering the market growth. Huge R&D required and poor awareness among the people regarding the Lyme diseases are further restricting the market from unleashing its fullest growth potential.

REPORT COVERAGE

COUNTRY LEVEL ANALYSIS

Based on the region, the rising focus of key players on enhancing their market presence across the globe is estimated to encourage the growth of the Latin American region. Since 2018, the Latin American Lyme Disease Diagnostics was hiking steadily, and the same is forecasted to happen during the forecast period. In this region, the Brazilian market is expected to have promising growth during the forecast period. The investments made by the government of Brazil are predicted to provide superior quality of clinical suspicions. Hence, the betterment of epidemiological information helps in the understanding of Lyme diseases.

The Brazilian Health System has come forward to create awareness in people about the Lyme-like borreliosis. The rising number of tick-borne infectious disease cases, accumulating vector-borne diseases, and intensifying healthcare expenses amplify industry growth. The rising demand for diagnostic tests and the increasing prevalence of new diagnostic tests for testing and identifying the diseases intensify industry growth. 

KEY MARKET PLAYERS

Noteworthy Companies dominating the Latin America Lyme Disease Diagnostics Market Profiled in the Report are Boulder Diagnostics, Immunetics Inc, GlaxoSmithKline Pharmaceuticals Ltd, Bio-Rad Laboratories, Alere Inc (ALR), Roche Diagnostics International Ltd, Graphene Frontiers, Covance Inc, Affymetrix Inc, Siemens AG, Baxter International Inc, Fresenius Medical Care AG & Co.

MARKET SEGMENTATION

This Latin America lyme disease diagnostic market research report is segmented and sub-segmented into the following categories.

By Diagnostic Tests

• Darkfield microscopy
• Urine antigen tests
• lymphocytic transformation test
• Serological tests
• immunofluorescence staining
• PCR tests

By Diagnostic Technologies

• Molecular diagnostics
• Monoclonal antibodies
• Flow cytometry
• Brain MRI
• Spinal tap
• Echocardiogram
• Electrocardiogram
• Microdroplets

By End User

• Hospitals/clinics
• Pharmaceutical Industries
• Pathology labs
• Research Institutes

By Country

• Brazil
• Mexico
• Argentina
• Chile
• Rest of Latin America